Carolina Liquid Chemistries Corp.

Carolina Liquid Chemistries Corp. manufactures and distributes clinical laboratory analyzers and reagents for physician offices, hospitals, and reference laboratories of all sizes. The company's core product portfolio includes the CLC Family of fully automated benchtop and high-volume chemistry analyzers (DZ-Lite c270, CLC800, CLC1600, CLC6410), offering throughputs from 270 to 1,600 tests/hour with integrated ion-selective electrode (ISE) capabilities. CLC markets Tosoh immunoassay analyzers (AIA-360, AIA-900, AIA-2000) and the G8 HPLC analyzer for HbA1c testing, as well as Mindray hematology analyzers (BC-3600, BC-5390). The company supplies a comprehensive reagent line covering 40 general chemistries, 27 urine drug screening assays, 15 immunochemistry tests, and 24 special chemistries including Lp-PLA2, Vitamin D, Procalcitonin, and Human Kappa/Lambda Free Light Chains. CLC offers refurbished Olympus AU and BioLIS 24i/CLC480 chemistry analyzers as cost-effective solutions. The company serves small, rural, and critical access hospitals, providing support for CLIA-regulated testing and maintaining compliance with Clinical Laboratory Improvement Amendments. CLC holds CLIA moderate-complexity categorization for its ethyl alcohol assay and maintains focus on reducing cost, space, and turnaround times for clinical laboratories. The company targets federal buyers including Veterans Affairs (VA) and Department of Defense (DoD) customers. CLC reports over 95% customer satisfaction year-over-year and provides comprehensive service and support infrastructure.